Skip to main content
ZYUS Life Sciences Corporation logo

ZYUS Life Sciences Corporation — Investor Relations & Filings

Ticker · ZYUS ISIN · CA9899601095 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 142 across all filing types
Latest filing 2026-04-16 Regulatory Filings
Country CA Canada
Listing TSXV ZYUS

About ZYUS Life Sciences Corporation

https://www.zyus.com/

ZYUS Life Sciences Corporation is a clinical-stage life sciences company dedicated to the development and commercialization of novel, non-opioid pharmaceutical drug candidates. The company focuses on proprietary cannabinoid-based therapeutics, or phyto-therapeutics, targeting the treatment of chronic and neuropathic pain. ZYUS's vision is to redefine the standard of care in pain management by developing evidence-based alternatives to conventional treatments, including opioids and NSAIDs. The core business involves advancing these drug product candidates through clinical trials, exemplified by the ongoing Phase 2a UTOPIA-1 trial evaluating a novel non-opioid pain drug.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a corporate press release announcing a clinical trial milestone (completion of last patient final visit in a Phase 2a trial), with forward-looking statements and no financial results, share issuance, management changes, voting, or regulatory form filing. It does not fit any specific S&P category, so it falls into the fallback category ‘Regulatory Filings’ (RNS).
2026-04-16 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a corporate news release announcing an update on its previously announced non-brokered private placement (unit offering), providing details on gross proceeds, tranche closures, and financing activity. This is clearly an update on fundraising/financing activities, matching the “Capital/Financing Update” category.
2026-04-11 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a corporate press release providing an update on a previously announced non-brokered private placement (“the Offering”), detailing gross proceeds raised, tranche closures, and ongoing financing needs. It is focused exclusively on fundraising activities, not a full financial report or regulatory filing. This aligns precisely with the “Capital/Financing Update” category (Code: CAP).
2026-04-11 English
Report of exempt distribution (45-106F1).pdf
Share Issue/Capital Change Classification · 1% confidence The document is Form 45-106F1 “Report of Exempt Distribution,” a Canadian regulatory form detailing an exempt securities distribution (i.e., new share/unit issuance). This is not an earnings release, annual report, or AGM material but a compliance filing for a financing event (issuance of new securities). Under the provided taxonomy, this best fits “Share Issue/Capital Change” (SHA).
2026-04-10 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a completed Form 45-106F1 "Report of Exempt Distribution," which is a mandatory regulatory filing in Canada disclosing details of a prospectus‐exempt securities distribution. It is neither an earnings release, annual or interim report, nor a presentation or proxy, but rather a specific compliance form filed with SEDAR under National Instrument 45-106. There is no bespoke category for NI 45-106 forms, so it falls under the general Regulatory Filings category.
2026-04-10 English
Material change report - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a Canadian NI 51-102 Form 51-102F3 Material Change Report describing the closing of the first tranche of a non-brokered private placement (financing) by ZYUS Life Sciences. It provides detailed terms of the unit offering and proceeds usage, clearly constituting an update on the company's fundraising activity. This fits the definition of a Capital/Financing Update (CAP), which covers announcements of company fundraising, financing activities, or capital structure changes. Therefore, the correct classification is CAP.
2026-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.